Aarkstore - Febrile Neutropenia-Pipeline Insights, 2014

1
Febrile Neutropenia-Pipeline Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/healthcare/77059/-febrile
  -neutropenia-pipeline-insights-2014

2
Summary

• DelveInsights, Febrile Neutropenia-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  indication. A key objective of the report is to
  establish the understanding for all the pipeline
  drugs that fall under Febrile Neutropenia. This
  report provides information on the therapeutic
  development based on the Febrile Neutropenia
  dealing with all the pipeline drugs, comparative
  analysis at various stages covering Filed, Phase
  III, Phase II, Phase I, IND filed, Preclinical,
  Discovery and unknown stages, therapeutics
  assessment by monotherapy and combination
  products and molecule type drug information. The
  report also covers the companies information
  involved in the therapeutic development of the
  products. It also has highlighted the
  discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Note This report requires
  certain updates. We have all the information
  available but require 3 business days to complete
  the process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated Indication.

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Febrile NeutropeniaThe
  report provides pipeline products under drug
  profile section which includes product
  description, MOA, licensors collaborators,
  development partner and chemical
  informationCoverage of the Febrile Neutropenia
  pipeline on the basis of target, MOA, route of
  administration, technology involved and molecule
  typeThe report reviews key players involved in
  the therapeutics development for Febrile
  Neutropenia and also provide company
  profilingThe report also gives the information
  of dormant and discontinued pipeline
  projects Pipeline products coverage based on
  various stages of development ranging from
  preregistration till discovery and undisclosed
  stages Provides pipeline assessment by
  monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete Pipeline intelligence
  and complete understanding over therapeutics
  development for Febrile Neutropenia
• Identify the relationship between the drugs and
  use it for target finding, drug repurposing, and
  precision medicine.
• Devise corrective measures for pipeline projects
  by understanding Febrile Neutropenia pipeline
  depth and focus of Indication therapeutics
• Developing strategic initiatives to support your
  drug development activities.
• Optimize your portfolio and keep you in touch
  with the rapidly changing pharmaceutical markets,
  and make the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and Scope
• Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies
• Modify the therapeutic portfolio by identifying
  discontinued projects and understanding the
  factors that drove them from pipeline
• Gaining a Full Picture of the Competitive
  Landscape for Evidence based Decisions
• You can order full Report with TOC and for Sample
  page visit _at_
• http//www.aarkstore.com/healthcare/77059/-febril
  e-neutropenia-pipeline-insights-2014

7
Table of Content

• Febrile Neutropenia OverviewFebrile Neutropenia
  Pipeline TherapeuticsFebrile Neutropenia
  Therapeutics under Development by
  Companies Febrile Neutropenia Late Stage
  Products (Filed and Phase III)Comparative
  Analysis Febrile Neutropenia Mid Clinical Stage
  Products (Phase II)Comparative Analysis Febrile
  Neutropenia Early Clinical Stage Products (Phase
  I and IND Filed)Comparative Analysis Febrile
  Neutropenia Discovery and Pre-Clinical Stage
  Products Comparative Analysis Drug Candidate
  Profiles

8
Table of Content

• Febrile Neutropenia Therapeutics
  Assessment Assessment by Monotherapy
  Products Assessment by Combination
  Products Assessment by Route of
  Administration Assessment by Molecule
  Type Febrile Neutropenia Discontinued
  Products Febrile Neutropenia Dormant
  ProductsCompanies Involved in Therapeutics
  Development for Febrile Neutropenia Appendix Met
  hodology Contact Us Disclaimer

9
List of Tables

• Number of Products under Development for Febrile
  Neutropenia, 2014Number of Products under
  Development by Companies Comparative Analysis by
  Late Clinical Stage Products (Filed and Phase
  III), 2014Comparative Analysis Mid Clinical
  Stage Products (Phase II), 2014Comparative
  Analysis Early Clinical Stage Products (Phase I
  and IND Filed), 2014Comparative Analysis
  Discovery and Pre-Clinical Stage Products,
  2014Drug Candidates ProfilesFebrile Neutropenia
  Assessment by Monotherapy Products Febrile
  Neutropenia Assessment by Combination Products 

10
List of Tables

• Febrile Neutropenia Assessment by Route of
  Administration Febrile Neutropenia Assessment by
  Stage and Route of Administration Febrile
  Neutropenia Assessment by Molecule Type Febrile
  Neutropenia Assessment by Stage and Molecule
  Type Febrile Neutropenia Therapeutics
  Discontinued Products Febrile Neutropenia
  Therapeutics Dormant ProductsProducts under
  Development by Companies, 2014

11
List of Figures

• Number of Products under Development for Febrile
  Neutropenia, 2014Late Clinical Stage Products
  (Filed and Phase III), 2014Mid Clinical Stage
  Products (Phase II), 2014Early Clinical Stage
  Products (Phase I and IND Filed), 2014Discovery
  and Pre-Clinical Stage Products, 2014Febrile
  Neutropenia Assessment by Monotherapy
  Products Febrile Neutropenia Assessment by
  Combination Products Febrile Neutropenia
  Assessment by Route of Administration Febrile
  Neutropenia Assessment by Stage and Route of
  Administration Febrile Neutropenia Assessment by
  Molecule Type Febrile Neutropenia Assessment by
  Stage and Molecule Type

12
Related Reports

• 2015 Worldwide Medical Laboratories
  Industry-Industry Market Report
• 2015 Worldwide Pharmaceutical Preparation Mfg.
  Industry-Industry Market Report
• OncoPlex Diagnostics - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• MetaStat, Inc. - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Advanced Cell Diagnostics, Inc. - Pharmaceuticals
  Healthcare - Deals and Alliances Profile
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• Febrile Neutropenia-Pipeline Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights, Febrile Neutropenia-Pipeline
  Insights, 2014, report provides comprehensive
  insights about pipeline drugs across this
  indication.
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news